Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 72.03M P/E - EPS this Y -37.50% Ern Qtrly Grth -
Income -8.2M Forward P/E -5.30 EPS next Y -54.50% 50D Avg Chg 19.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 8.00%
Dividend N/A Price/Book 5.56 EPS next 5Y - 52W High Chg -43.00%
Recommedations 1.70 Quick Ratio 11.87 Shares Outstanding 25.93M 52W Low Chg 59.00%
Insider Own 64.22% ROA -65.97% Shares Float 3.91M Beta -1.02
Inst Own 28.18% ROE -113.80% Shares Shorted/Prior 17.99K/12.47K Price 2.81
Gross Margin - Profit Margin - Avg. Volume 3,079 Target Price 6.00
Oper. Margin - Earnings Date Nov 12 Volume 24,082 Change 8.91%
About Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

ANEB Chatroom

User Image Thestocktraderhubzee Posted - 1 day ago

WATCHLIST NOV 20 2024.. $ROST TD Cowen Maintains Buy on Ross Stores, Lowers Price Target to $177 $COF Goldman Sachs Maintains Buy on Capital One Finl, Raises Price Target to $205 $HRL Citigroup Maintains Buy on Hormel Foods, Lowers Price Target to $35 $EHAB Leerink Partners Reiterates Market Perform on Enhabit, Lowers Price Target to $8 $ANEB Benchmark Reiterates Speculative Buy on Anebulo Pharmaceuticals, Maintains $8 Price Target

User Image PenkeTrading Posted - 09/25/24

I found you a Three Black Crows Candle Pattern on the daily chart of Anebulo Pharmaceuticals Inc. $ANEB #Anebulo #ThreeBlackCrows #NASDAQ

User Image DonCorleone77 Posted - 09/25/24

$ANEB Anebulo Pharmaceuticals reports Q4 EPS (5c) vs. (10c) last year "The recently awarded grant from NIDA further enables our efforts to provide a rapid and clinically impactful emergency treatment for acute cannabis-induced toxicities, including cannabis-induced Central Nervous System depression in children," commented Richie Cunningham, CEO. "We believe this important grant from NIDA recognizes the progress we have already made with the successful Phase 2 proof of concept study of oral selonabant and provides further momentum for advancing the intravenous formulation towards clinical testing. We also believe this awarded grant further validates the significant and growing unmet medical need for an emergency antidote to cannabis toxicity. In particular, acute cannabis exposure in children is a serious and potentially life-threatening condition that can result in CNS depression, respiratory depression, coma, and in rare cases death. Research has shown that children are much more sensitive to the toxic effects of cannabis, due in part to age-related differences in the abundance of cannabis receptors in their brains. As a direct consequence, pediatric cannabis ingestion can result in much more serious outcomes than in adults, and a much greater risk of hospitalization and admission to intensive care. If approved, we believe selonabant has the potential to offer a much-needed targeted therapy for rapidly reversing the serious and life-threatening consequences of accidental cannabis ingestion in children."

User Image Stock_Titan Posted - 09/25/24

$ANEB Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates https://www.stocktitan.net/news/ANEB/anebulo-pharmaceuticals-reports-fourth-quarter-and-fiscal-year-2024-ztaj3piyhbao.html

User Image HaltTradeAlert Posted - 09/23/24

$ANEB Halt Time: 11:26:42 Issue Symbol: ANEB Reason Code: LUDP Last Price: $2.6 Volume: 56.5 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image StockBoyAri Posted - 09/23/24

$ANEB started a position here. I like the dip.

User Image itsphd Posted - 2 months ago

$ANEB What the heck just happened lol? I scalped 99 shares for 11 dollars and then this thing rockets up $1???

User Image Himel92 Posted - 2 months ago

The Last month Performance for $ANEB Opening Price: $1.83 Closing Price: $2.09 Highest Price: $2.09 Lowest Price: $1.72 Percentage Change: 14.21% Data analyst: AITX

User Image itsphd Posted - 2 months ago

$ANEB I'm slowly trying to build a small position here or lower. I believe either candidate may try and de-criminalize weed consumption but that will lead to more potential patients.

User Image BioTuesdays Posted - 07/22/24

Anebulo announces NIDA grant for investigational treatment of acute cannabis-induced toxicities in children $ANEB https://biotuesdays.com/2024/07/22/anebulo-announces-nida-grant-for-investigational-treatment-of-acute-cannabis-induced-toxicities-in-children/

User Image DonCorleone77 Posted - 07/22/24

$ANEB Anebulo gets $1.9M cooperative grant award from NIDA for intravenous selonabant Anebulo Pharmaceuticals has been awarded the first tranche of a two year cooperative grant of up to approximately $1.9M from the National Institute on Drug Abuse NIDA part of the National Institutes of Health NIH to support the development of intravenous selonabant, for the potential use as an emergency treatment of acute cannabis-induced toxicities, including cannabis-induced CNS depression in children. The grant comes in the form of two tranches with the initial award of $0.9 million and subsequent funding of approximately $1M subject to certain milestones. The grant was awarded under NIH award number 1U01DA059995-01. "We are honored to receive this cooperative grant award from NIDA to support the further development of intravenous selonabant," commented Ken Cundy, CSO of Anebulo Pharmaceuticals. "We believe this provides additional validation of the significant and growing unmet medical need for an emergency antidote to cannabis. Acute cannabis exposure in children represents a potentially life-threatening condition that can result in CNS depression, respiratory depression, coma, and in rare cases death. Research has shown that children are much more sensitive to the toxic effects of cannabis. Younger children have an underdeveloped endocannabinoid system with significantly more of the primary cannabinoid receptor type 1 receptors present in their brains. As a direct consequence, pediatric cannabis ingestion can result in much more serious outcomes than in adults, and a much greater risk of hospitalization and admission to intensive care."

User Image Stock_Titan Posted - 07/22/24

$ANEB Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects https://www.stocktitan.net/news/ANEB/anebulo-pharmaceuticals-awarded-nida-grant-for-its-investigational-ds06cnoh6sxp.html

User Image NVDAMillionaire Posted - 4 months ago

$ANEB Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB): Rapidly Advancing a Novel Treatment for Acute Cannabinoid Intoxication http://beyondspx.com/2024/07/12/anebulo-pharmaceuticals-inc-nasdaqaneb-rapidly-advancing-a-novel-treatment-for-acute-cannabinoid-intoxication/

User Image tradingtwenty Posted - 4 months ago

$LGND $ANEB $LFCR $QLGN has trended 51 times in the past 24 hours (based on 5 minute intervals). Latest press release on Jul 01, 2024 08:00 AM: Lifecore Biomedical Announces Cooperation Agreement with 22NW Link: https://tradingtwenty.com/news/531088/lifecore-biomedical-announces-cooperation-agreement-with-22nw

User Image TickerDD_com Posted - 4 months ago

From 6/24/2024, looking back across 21 Month-Ends for ANEB, Percentage Change of Average Monthly Price had More Positives (64%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ANEB #ANEB #ANEBStock #TickerDD #ANEBPrice https://www.youtube.com/watch?v=S0Qf9dQGBGM

User Image juanitoconpower Posted - 06/25/24

$NXL $SPEC $ANEB Taking profits and moving to buy more shares here $PRST

User Image juanitoconpower Posted - 06/22/24

$NXL $SPEC $ANEB Moving to this with more shares of this on Monday $PRST

User Image The_bag_breaker Posted - 5 months ago

$DWTX A beauty, it is beautiful to see that every day it rises more and more, it already generates profits for me, and waiting for it to still explode, it will be like this $ANEB $UBXG

User Image Stocksrunner Posted - 5 months ago

🚀 Top Gainers of the Day! 🎉 $AREB, $SHCR, $NXL, $ANEB, $INUV 🚀🔥 These stocks skyrocketed today!

User Image Stock_Titan Posted - 6 months ago

$ANEB Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates https://www.stocktitan.net/news/ANEB/anebulo-pharmaceuticals-reports-third-quarter-fiscal-year-2024-ei5l13oadi09.html

User Image Austero Posted - 6 months ago

$MEDH getting current. watch the 🚀 $ANEB $SNDL $TLRY

User Image Austero Posted - 6 months ago

Would like to masssively swing trade $MEDH Cannabis/Coffee franchise into $ANEB Cannabis Antidote. Anebulo has been consoldating for a while now…

User Image Doozio Posted - 7 months ago

$ANEB chop chop huckleberries 🧠⏰

User Image luminouslumens Posted - 03/27/24

$ANEB 🧐

User Image TickerDD_com Posted - 9 months ago

From 2/16/2024, looking back across 22 Month-Ends for ANEB, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ANEB #ANEB #ANEBStock #TickerDD #ANEBPrice https://www.youtube.com/watch?v=GFxAnZ4fpAw

User Image Stock_Titan Posted - 9 months ago

$ANEB Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates https://www.stocktitan.net/news/ANEB/anebulo-pharmaceuticals-reports-second-quarter-fiscal-year-2024-mrea5eb99cbz.html

User Image JamieFox657 Posted - 9 months ago

$ANEB & TNXP: Market-ready and raring. Glance at their prep!

User Image VirmoMopire Posted - 01/30/24

$ANEB Just spotted some interesting activity on this one. 🧐

User Image hitmongreen Posted - 12/29/23

$ANEB 👀

User Image tickeron Posted - 12/26/23

A.I.dvisor made a bullish call on $ANEB, netting in a 17.80% gain over 1 week https://srnk.us/go/4951602

Analyst Ratings
Benchmark Speculative Buy Oct 1, 24
Benchmark Speculative Buy Oct 3, 23
HC Wainwright & Co. Buy Sep 25, 23
Maxim Group Buy Sep 21, 23
HC Wainwright & Co. Buy Sep 18, 23
Benchmark Speculative Buy May 18, 23
Benchmark Speculative Buy Feb 14, 23
Ladenburg Thalmann Buy Jul 27, 22
Benchmark Buy May 25, 21